Skip to content
Screener

Cue Biopharma CUE Q3 2025 earnings

Reported November 12, 2025 · Before market open

Revenue$2.1MMiss by $140.7K
EPS-$0.07Beat by $0.03
Revenue estimate$2.3M
EPS estimate-$0.10

Next report

Nov 11, 2026 (In 1 week)
Revenue estimate$1.0M
EPS estimate-$2.24

FAQ

When did Cue Biopharma report Q3 2025 earnings?
Cue Biopharma (CUE) reported Q3 2025 earnings on November 12, 2025 before market open.
What were Cue Biopharma's Q3 2025 revenue and EPS?
Cue Biopharma reported revenue of $2.1M and eps of $-0.07 for Q3 2025.
Did Cue Biopharma beat estimates in Q3 2025?
Revenue missed the consensus estimate of $2.3M by $140.7K. EPS beat the consensus estimate of $-0.10 by $0.03.
How did Cue Biopharma's Q3 2025 results compare year-over-year?
Compared to the same quarter a year prior, revenue declined 35.6% from $3.3M a year earlier and eps grew 58.8% from $-0.17.
Where can I find Cue Biopharma's Q3 2025 SEC filings?
You can read the 8-K earnings release (0001193125-25-277468) and the 10-Q periodic report (0001193125-25-277466) directly on SEC EDGAR. The filing index links above go to sec.gov.